1. Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data 
Evelien Roekevisch, MD, Mandy Elvira Schram, MD, PhD, Mariska Maria Geertruida Leeflang, PhD, Marijke Willemijn Dorothée Brouwer, MD, Louise Anna Andrea Gerbens, MD, Jan Dositheus Bos, MD, PhD, FRCP, MPH, Phyllis Ira Spuls, MD, PhD 
Journal of Allergy and Clinical Immunology 
Volume 141, Issue 2, Pages e10 (February 2018)
DOI: /j.jaci
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig E1
Flowchart. *Three patients stopped treatment with AZA because of controlled AD, but restarted AZA after 6 to 9 months because of a relapse.
Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Fig E2
A, Mean (SD) total SCORAD index scores at baseline, 3 months, and 24 months (2 years) (ITT analysis). B, Mean (SD) total SCORAD index scores at baseline, 3 months and 24 months (2 years) (PP analysis).
Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4. Fig E3
A, Mean (SD) SCORAD index scores up to 2 years after baseline in patients with and without a filaggrin mutation (ITT analysis). B, Mean (SD) SCORAD index scores up to 2 years after baseline in patients with and without a filaggrin mutation (PP analysis).
Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions